Ireland - English - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - fenoprofen - tablets

Ireland - English - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - fenoprofen paracetamol - tablets

Ireland - English - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - fenoprofen - tablets - 200 milligram

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - capsules - see ingredients - each capsule contains fenoprofen calcium equivalent to 300 mg fenoprofen

United States - English - NLM (National Library of Medicine)

h.j. harkins company, inc. - diclofenac potassium (unii: l4d5ua6cb4) (diclofenac - unii:144o8ql0l1) - diclofenac potassium 50 mg - carefully consider the potential benefits and risks of diclofenac potassium tablets and other treatment options before deciding to use diclofenac potassium tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). diclofenac potassium tablets are indicated: - for treatment of primary dysmenorrhea - for relief of mild to moderate pain - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis diclofenac potassium tablets are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac potassium tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings , anaphylactic reactions and precautions , preexisting asthma ). diclofenac potassium tablets are contraindicate

Malta - English - Medicines Authority

wockhardt uk limited - acetylsalicylic acid - gastro-resistant tablet - acetylsalicylic acid 75 mg - antithrombotic agents

Canada - English - Health Canada

syntex inc. - ketorolac tromethamine - tablet - 10mg - ketorolac tromethamine 10mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

syntex inc. - ketorolac tromethamine - liquid - 10mg - ketorolac tromethamine 10mg - other nonsteroidal antiimflammatory agents

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - etodolac 400 mg - carefully consider the potential benefits and risks of etodolac extended-release tablets and other treatment options before deciding to use etodolac extended-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). etodolac extended-release tablets are indicated: - for relief of signs and symptoms of juvenile arthritis. - for relief of the signs and symptoms of rheumatoid arthritis. - for relief of the signs and symptoms of osteoarthritis. etodolac extended-release tablets are contraindicated in patients with known hypersensitivity to etodolac. etodolac extended-release tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma ). etodolac extended-release tablets are contr

United States - English - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - etodolac 500 mg - carefully consider the potential benefits and risks of etodolac extended-release tablets and other treatment options before deciding to use etodolac extended-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). etodolac extended-release tablets are indicated: - for relief of signs and symptoms of juvenile arthritis. - for relief of the signs and symptoms of rheumatoid arthritis. - for relief of the signs and symptoms of osteoarthritis. etodolac extended-release tablets are contraindicated in patients with known hypersensitivity to etodolac. etodolac extended-release tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma ). etodolac extended-release tablets are contr